CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.17B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.53: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.09%Below 5Y avg (1.34%)
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
57.5%Sustainable
Payback Period
91.1 yr
Last Ex-Dividend
Jun 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.86BCNY1.17B · vs all stocks (USD)
Trailing P/E
29.47xRevenue (TTM)
7.13BCNY1.06B · vs all stocks (USD)
Profit Margin
3.51%Beta
0.0630xvs all stocks
52-Week Change
-5.97%vs all stocks
Forward Annual Dividend Yield
1.09%vs all stocks
Market Capitalization
7.86BCNY1.17B · vs all stocks (USD)
Enterprise Value
5.15BCNY764.21M · vs all stocks (USD)
Trailing P/E
29.47xPrice to Sales (TTM)
1.00xPrice to Book (MRQ)
1.29xEnterprise to Revenue
0.7220xEnterprise to EBITDA
7.11xGross Margin
28.44%Profit Margin
3.51%Operating Margin
4.90%Return on Assets (TTM)
1.04%Return on Equity (TTM)
3.52%Revenue (TTM)
7.13BCNY1.06B · vs all stocks (USD)
Revenue per Share (TTM)
4.98CNYUpdated Aug 18, 2026Quarterly Revenue Growth
3.00%Gross Profit (TTM)
2.34BCNY346.46M · vs all stocks (USD)
EBITDA (TTM)
566.91MCNY84.07M · vs all stocks (USD)
Net Income (TTM)
250.38MCNY37.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-26.70%Operating Cash Flow (TTM)
1.15BCNY171.16M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
918.22MCNY136.17M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600CNYUpdated Aug 18, 2026Forward Annual Dividend Yield
1.09%vs all stocks
Trailing Annual Dividend Rate
0.0550CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
1.09%vs all stocks
5-Year Average Dividend Yield
1.34%vs all stocks
Payout Ratio
57.47%Minority Interest (Equity)
139.40MCNYFY2025 · Dec 31, 2025Revenue
7.07BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.44BCNYFY2025 · Dec 31, 2025Gross Profit
2.64BCNYFY2025 · Dec 31, 2025Operating Income
498.81MCNY73.97M · vs all stocks (USD)
Pre-tax Income
305.26MCNYFY2025 · Dec 31, 2025Income Tax Expense
87.43MCNYFY2025 · Dec 31, 2025Net Income
217.83MCNYFY2025 · Dec 31, 2025EBIT
354.43MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.07BCNYFY2025 · Dec 31, 2025Research & Development
172.27MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.41BCNYFY2025 · Dec 31, 2025Other Operating Expenses
114.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
90.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
49.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
217.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
42.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
511.03MCNYFY2025 · Dec 31, 2025Free Cash Flow
418.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.85BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
217.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
100.20MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
101.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
91.42MCNYFY2025 · Dec 31, 2025Capital Expenditures
-92.23MCNYFY2025 · Dec 31, 2025Purchase of Investments
-50.29MCNYFY2025 · Dec 31, 2025Sale of Investments
53.16MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-89.37MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.85BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.33BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-196.90MCNYFY2025 · Dec 31, 2025Other Financing Charges
-555.85MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-238.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.43BSharesUpdated Aug 18, 2026Float Shares
579.67MSharesUpdated Aug 18, 2026% Held by Insiders
60.49%vs all stocks
% Held by Institutions
1.51%vs all stocks
Total Cash (MRQ)
3.97BCNY588.70M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.78CNYUpdated Aug 18, 2026Total Debt (MRQ)
1.84BCNY273.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3244xCurrent Ratio (MRQ)
1.15xBook Value per Share (MRQ)
3.89CNYUpdated Aug 18, 2026Total Assets
12.89BCNY1.91B · vs all stocks (USD)
Total Current Assets
7.53BCNYFY2025 · Dec 31, 2025Total Liabilities
7.22BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.36BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
655.91MCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.56BCNYFY2025 · Dec 31, 2025Cash
2.89BCNYFY2025 · Dec 31, 2025Cash Equivalents
713.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.60BCNYFY2025 · Dec 31, 2025Other Short-term Investments
350.62KCNYFY2025 · Dec 31, 2025Accounts Receivable
1.73BCNYFY2025 · Dec 31, 2025Inventory
1.18BCNYFY2025 · Dec 31, 2025Accounts Payable
2.86BCNYFY2025 · Dec 31, 2025Short-term Debt
1.97BCNYFY2025 · Dec 31, 2025Other Current Liabilities
108.17MCNYFY2025 · Dec 31, 2025Long-term Debt
174.42MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
261.56MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.43BCNYFY2025 · Dec 31, 2025Retained Earnings
1.37BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.67BCNY840.75M · vs all stocks (USD)
Treasury Stock
2.47MCNYFY2025 · Dec 31, 202552-Week Low
4.09CNYUpdated Aug 18, 202652-Week High
5.93CNYUpdated Aug 18, 202652-Week Change
-5.97%vs all stocks
Beta
0.0630xvs all stocks
50-Day MA
4.57CNYUpdated Aug 18, 2026200-Day MA
5.08CNYUpdated Aug 18, 2026Avg 10-Day Volume
18.16MSharesUpdated Aug 18, 2026Avg 30-Day Volume
15.35MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
0.1700CNYUpdated Aug 18, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.53: grey zoneSignificant
Altman Z-Score: 1.53
High earnings qualityNotable
Earnings Quality Score: 0.55
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.17B, above the global median of $1.15BNotable
Market cap (USD): 1,166,120,915.222Global Median: 1,146,734,693.424
Revenue is $1.06B, above the global median of $520.53MNotable
Revenue (USD): 1,057,938,658.099Global Median: 520,528,949.311
Levered free cash flow is $136.17M, above the global median of $16.24MNotable
Levered free cash flow (USD): 136,172,619.2Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Sinomach General Machinery Co., Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt
Jiangsu Kanion Pharmaceutical Co., Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt
Shanghai New Huang Pu Real Estate Co. Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt